Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T20278
(Former ID: TTDI01647)
|
|||||
Target Name |
Major histocompatibility complex (MHC)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Discontinued target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Virus infection [ICD-11: 1A24-1D9Z] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Discontinued Drug(s) | [+] 1 Discontinued Drugs | + | ||||
1 | Theradigm-HBV | Drug Info | Discontinued in Phase 2 | Virus infection | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | Theradigm-HBV | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor. Hepatology. 1997 Oct;26(4):1027-34. | |||||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004156) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.